CoreRx to formulate and manufacture JanOne’s peripheral artery disease candidate

pharmanewsdaily- February 7, 2020 0

JanOne has signed a manufacturing agreement with cGMP contract manufacturer CoreRx for the clinical formulation and manufacturing of its lead drug candidate TV1001SR, a potential ... Read More